An independent study of five experts says the FDA does not have the authority to pull dangerous drugs unilaterally, force changes in drug labels, or sanction drug companies that skimp on safety monitoring.
The independent study recently published its critique in the Archives of Internal Medicine. The study also contended that the FDA lacks the money and structure to insulate itself from the influence of the pharmaceutical industry. The FDA is aware of these problems and as done very little to fix them. (Washington Post)